Updates on EMA Guideline on Good Pharmacovigilance Practice

Two of the updated Modules will become effective in November 2017

The EMA’s GVP Guideline consists of several modules, two coming into effect in November after a revision:

Module VI: Collection, Management and Submission of Reports of suspected Adverse Reactions to Medical Products (including Addendum I)

Module IX: Signal Management (including Addendum I)

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /